Review
Development of PARP inhibitors: an unfinished story
Affiliations
- PMID: 20187324
Item in Clipboard
Review
Development of PARP inhibitors: an unfinished story
Oncology (Williston Park).
2010 Jan.
Free article
No abstract available
Comment on
-
Inhibition of poly(ADP)-ribose polymerase as a therapeutic strategy for breast cancer.Oncology (Williston Park). 2010 Jan;24(1):55-62. Oncology (Williston Park). 2010. PMID: 20187322 Review.
Similar articles
-
PARP inhibitors in BRCA1-/BRCA2-associated and triple-negative breast cancers.Future Oncol. 2010 Apr;6(4):485-6. doi: 10.2217/fon.10.27. Future Oncol. 2010. PMID: 20373860 No abstract available.
-
PARP inhibitors: targeting the right patients.J Natl Cancer Inst. 2012 Dec 19;104(24):1851-2. doi: 10.1093/jnci/djs514. Epub 2012 Dec 10. J Natl Cancer Inst. 2012. PMID: 23231976 No abstract available.
-
An Achilles' heel for breast cancer?Nat Struct Mol Biol. 2005 May;12(5):387-8. doi: 10.1038/nsmb0505-387. Nat Struct Mol Biol. 2005. PMID: 15870726 No abstract available.
-
PARP inhibitors: what we know and what we have yet to know.Oncology (Williston Park). 2010 Jan;24(1):62, 65-6. Oncology (Williston Park). 2010. PMID: 20187323 Review. No abstract available.
-
Molecular pathways: how can BRCA-mutated tumors become resistant to PARP inhibitors?Clin Cancer Res. 2014 Feb 1;20(3):540-7. doi: 10.1158/1078-0432.CCR-13-0225. Epub 2013 Nov 22. Clin Cancer Res. 2014. PMID: 24270682 Review.
Cited by
-
Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP.J Hematol Oncol. 2011 Apr 20;4:16. doi: 10.1186/1756-8722-4-16. J Hematol Oncol. 2011. PMID: 21504625 Free PMC article. Review.
-
A single nucleotide variant of human PARP1 determines response to PARP inhibitors.NPJ Precis Oncol. 2020 Apr 27;4:10. doi: 10.1038/s41698-020-0113-2. eCollection 2020. NPJ Precis Oncol. 2020. PMID: 32352035 Free PMC article.
-
Drug treatment of cancer cell lines: a way to select for cancer stem cells?Cancers (Basel). 2011 Mar 4;3(1):1111-28. doi: 10.3390/cancers3011111. Cancers (Basel). 2011. PMID: 24212655 Free PMC article.
-
Insights into the binding of PARP inhibitors to the catalytic domain of human tankyrase-2.Acta Crystallogr D Biol Crystallogr. 2014 Oct;70(Pt 10):2740-53. doi: 10.1107/S1399004714017660. Epub 2014 Sep 27. Acta Crystallogr D Biol Crystallogr. 2014. PMID: 25286857 Free PMC article.
-
Persistence of cisplatin-induced mutagenicity in hematopoietic stem cells: implications for secondary cancer risk following chemotherapy.Toxicol Sci. 2014 Aug 1;140(2):307-14. doi: 10.1093/toxsci/kfu078. Epub 2014 May 5. Toxicol Sci. 2014. PMID: 24798381 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
